X hits on this document

Word document

I.EXECUTIVE ORDERS - page 204 / 359

1497 views

0 shares

0 downloads

0 comments

204 / 359

consistent with current Center for Disease Control and Prevention guidelines, which include the following specifications:

1.administration of a risk assessment questionnaire at every well baby visit;
2.use a blood lead test to screen all children at ages 12 months and at 24 months or at any time from ages 36 months to 72 months, if they have not been previously screened;
3.blood lead levels >15μg/dl obtained from finger stick samples will be confirmed using a venous blood sample.

C.Identified high-risk areas will be assessed annually and any additions or deletions will be provided through amendment of LAC 48:V.7005.

AUTHORITY NOTE:Promulgated in accordance with R.S. 49:950 et seq., and under the authority of R.S. 40:5, 40:1299.21, 40:1299.22, 40:1299.23, and 40:1299.25.

HISTORICAL NOTE:Promulgated by the Department of Health and Hospitals, Office of Public Health, LR 31:1588 (July 2005), amended LR 34:2173 (October 2008).

§7007.Mandatory Case Reporting by Health Care Providers

A.Medical providers must report a lead case, which is indicated by a blood lead test result of >15μg/dl (micrograms per deciliter), to the Childhood Lead Poisoning Prevention Program, Office of Public Health within 24 working hours to ensure appropriate and timely follow-up. All health care providers shall assure that all the following information is submitted to the testing laboratory with all ordered blood lead samples for analysis and/or submitted with all lead case reports to the Lead Poisoning Prevention Program:

1.child's name;
2.parent's or the guardian's name;
3.child's street and mailing address, including the city state, parish, and zip code;
4.child's date of birth;
5.child's sex;
6.child's race;
7.child's national origin;
8.child's Social Security number;
9.phone number where child’s parent(s) or guardian can be reached;
10.Medicaid number if child is an enrolled recipient;
11.type of sample (venous or capillary);
12.sample collection date
13.type of test: first, annual, or repeat test;
14.blood lead level results documented in micrograms per deciliter (μg/dl).

B.Lead cases, along with the specified information shall be reported within 24 business hours by fax to the Lead Poisoning Prevention Program, Office of Public Health at 504-219-4452 and the original lead case reporting form shall be mailed within five business days to the Louisiana Lead Poisoning Prevention Program Office at 3101 W. Napoleon Ave, Metairie, LA 70001.

AUTHORITY NOTE:Promulgated in accordance with R.S. 49:950 et seq., and under the authority of R.S. 40:5; 40:1299.21; 40:1299.22, 40:1299.23, and 40:1299.25.

HISTORICAL NOTE:Promulgated by the Department of Health and Hospitals, Office of Public Health, LR 26:85, (January 2000); amended LR 27:52 (January 2001); LR 31:1588 (July 2005), LR 34:2174 (October 2008).

§7009.Reporting Requirements of Blood Lead Levels by Laboratories and by Health Care Providers Performing Office-Based Blood Lead Analyses for Public Health Surveillance

A.Health care providers who conduct blood lead level screenings using a CLIA-waived blood lead analysis device to determine blood lead levels and clinical laboratories responsible for conducting analysis to determine blood lead levels for health care providers and/or for referring laboratories, shall also report all results to the Louisiana Lead Poisoning Prevention Program by electronic transmission in a format consistent with the CDC guidelines for uniform reporting of blood lead results to state and local health departments as available at http://lcweb2.loc.gov/lasw/usa/1710299992p1106-310.pdf.

B.The following information is required and essential for appropriate monitoring, screening and treatment of lead poisoning.

1.All results of blood lead testing for children under 72 months of age must be reported regardless of the test results
2.All laboratories responsible for directly conducting blood lead level analyses and laboratories responsible for referring the analysis to another laboratories must collect all the information specified in items under §7007.A.1-14.from the health care provider.

AUTHORITY NOTE:Promulgated in accordance with R.S. 49:950 et seq., and under the Authority of R.S. 40:5; 40:1299.21; 40:1299.22, 40:1299.23, and 40:1299.25.

HISTORICAL NOTE:Promulgated by the Department of Health and Hospitals, Office of Public Health, LR 26:85, (January 2000); amended LR 27:52 (January 2001); LR 31:1588 (July 2005), LR 34:2174 (October 2008).

Alan Levine

Secretary

0810#097

RULE

Department of Health and Hospitals

Office of Public Health

Marine and Freshwater Animal Food Products (LAC 51:IX.101, 145, 321, 327, 329, 331 and 333)

In accordance with the Administrative Procedure Act, R.S. 49:950 et seq., that the state health officer acting through the Department of Health and Hospitals, Office of Public Health, pursuant to the authority in R.S. 40:4(A)(6) and R.S. 40:5, amended Title 51, Part IX (Marine and Fresh Water Animal Food Products), by effecting substantive changes as outlined below. The changes will result in code provisions which are consistent with the National Shellfish Sanitation Program (NSSP) 2005 Model Ordinance. The NSSP is the federal/state cooperative program recognized by the U.S. Food and Drug Administration (FDA) and the Interstate Shellfish Sanitation Conference (ISSC) for the sanitary control of shellfish produced and sold for human consumption.

Title 51

PUBLIC HEALTH—SANITARY CODE

Louisiana Register   Vol. 34, No. 10   October 20, 2008

Document info
Document views1497
Page views1500
Page last viewedSat Dec 03 12:50:04 UTC 2016
Pages359
Paragraphs18243
Words293762

Comments